p53 and ras mutations in Ewing's sarcoma

Pathology Research and Practice

Volumn 194, Issue 3, 1998, Pages 157-162

  Radig, Kathrin ^a   Schneider Stock, Regine ^a   Röse, Ingeborg ^a   Mittler, Uwe ^a   Oda, Yoshinao ^b   Roessner, Albert ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Ewing's sarcoma; Immunohistochemistry; MDM2; p53; ras Gene mutations

Indexed keywords

PROTEIN P53;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CODON; EWING SARCOMA; EXON; FEMALE; GENE FREQUENCY; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; ONCOGENE RAS; OSTEOSARCOMA; POINT MUTATION; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

EID: 0031921885     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0344-0338(98)80016-2     Document Type: Article

References (41)

1. Barbacid M (1987) ras Genes. Ann Rev Biochem 56: 779-827
2. Castresana JS, Rubio MP, Vazquez JJ, Idoate M, Sober AJ, Seizinger BR, Barnhill RL (1993) Lack of allelic deletion and point mutation as mechanism of p53 activation in human malignant melanoma. Int J Cancer 55: 562-565
3. Dehner LP (1993) Primitive neuroectodermal tumor and Ewing's sarcoma. Am J Surg Pathol 17: 1-13
4. Felix CA, Slavc I, Dunn M (1995) p53 gene mutations in pediatric brain tumors. Medical Pediatric Oncol 25: 431-436 81995)
5. Glaubiger DL, Makuch R, Schwar J, Levin AS, Johnson RE (1980) Determination on prognostic factors and their influence on therapeutic results in patients with Ewing's sarcoma. Cancer 45: 2213-2219
6. Goldman D, Merril CR (1982) Silver staining of DNA in polyacrylamide gels: Linearity and effect of fragment size: Electrophoresis 3: 24-26
7. Hamelin R, Zucman J, Melot T, Delattre O, Thomas G (1994) p53 mutations in human tumors with chimeric EWS/FLI-1 genes. Int J Cancer 57: 336-340
8. Hsieh LL, Hsia CF, Wang LY, Chen C, Ho Ys (1994) p53 gene mutations in brain tumors in Taiwan. Cancer Letters 78: 25-32
9. Jaffe N (1995) Cancer of bone in children. Pediatr Dent 17: 261-267
10. Jürgens H, Göbel V, Michaelis J, Ramach W, Ritter J, Sauer R, Treuner J, Voute PA, Winkler K, Göbel U (1985) Die kooperative Ewing-Sarkomstudie CESS 81 der GPO-Analyse nach 4 Jahren. Klin Pädiat 197: 225-232
11. Komuro H, Hayashi Y, Kawamura M, Hayashi K, Kaneko Y, Kamoshita S, Hanada R, Yamamoto K, Hongo T, Yamada M, Tsuchida Y (1993) Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas. Cancer Res 53: 5284-5288
12. Kovar H, Auinger A, Jug G, Aryee D, Zoubek A, Salzer-Kuntschik M, Gadner H (1993) Narrow spectrum of infrequent p53 mutations and absence of MDM2 amplification in Ewing tumours. Oncogene 8: 2683-2690
13. Ladanyi M, Cha C, Lewis R, Jhanwar SC, Huvos AG, Healey JH (1993) MDM2 gene amplification in metastatic osteosarcoma. Cancer Res 53: 16-18
14. Ladanyi M, Lewis R, Jhanwar SC, Gerald W, Huvos AG, Healey JH (1995) MDM2 and CDK4 gene amplification in Ewing's sarcoma. J Pathol 175: 211-217
15. Leach FS, Tokino T, Meltzer P (1993) p53 mutations and amplification in human soft tissue sarcomas. Cancer Res 53: 2231-2234
16. Levinson AD (1986) Normal and activated ras oncogenes and their products. TIG; 81-86
17. Lowe SW, Ruley HE, Jacks T, Housman DF (1993) p53-dependent apoptosis modulates the cytotoxity of anticancer agents. Cell 74: 957-967
18. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T (1993) p53 required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849
19. Mangham DC, Cannon A, Li XQ, Komiya S, Gebhardt MC, Springfield DS, Rosenberg AE, Mankin HJ (1995) p53 overexpression in Ewing's sarcoma/primitive neuroectodermal tumour is an uncommon event. J Clin Pathol: Mol Pathol 48: M79-M82
20. Miller CW, Aslo A, Tsay C, Slamon D, Ishizaki K, Toguchida J, Yamamuro T, Lampkin B, Koeffler HP (1990) Frequency and structure of p53 rearrangements in human osteosarcoma. Cancer Res 50: 7950-7954
21. Mulligan LM, Matlashewski GJ, Scrable HJ, Canenee WK (1990) Mechanisms of p53 loss in human sarcomas. Proc. Natl Acad Sci USA 87: 5863-5867
22. Nilbert M, Rydholm A, Willien H, Mitelman F, Mandahl N (1994) MDM2 gene amplification correlates with ring chromosomes in soft tissue tumors. Genes Chromosome Cancer 9: 261-265
23. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B (1992) Amplification of a gene encoding p53-associated protein in human sarcomas. Nature 358: 80-83
24. Orita M, Suzuki Y, Sekyia T, Hayashi K (1989) Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5: 874-879
25. Papp T, Jafari, Schiffmann D (1996) Lack of p53 mutations and loss of heterozygosity in no-cultured human melanocytic lesions. J Cancer Res Clin Oncol 122: 541-548
26. Patino-Garcia A, Sierrasesumaga L (1997) Analysis of the p16INK4 and TP53 tumor suppressor genes in bone sarcoma pediatrics patients. Cancer Genet Cytogenet 98: 50-55
27. Picksley SM, Lane DP (1993) The p53-mdm2 autoregulatory feedback loop. A paradigm for the regulation of growth control by p53? Bioassays 15: 689-690
28. Preudhomme C, Quesnel B, Vachee A (1993) Absence of amplification of MDM2 gene, a regulator of p53 function, in myelodysplastic syndromes. Leukemia 7: 1291-1293
29. Radig K, Schneider-Stock R, Oda Y, Neumann W, Mittler U, Roesser A (1996) Mutation spectrum of p53 gene in highly malignant human osteosarcomas. Gen Diagn Pathol 142: 25-32
30. Reifenberger G, Liu L, Ichimura K, Schmidt EE, Collins VP (1993) Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res 53: 2736-2739
31. Ridge SA, Dyer M, Graves MF, Wiedemann LM (1994) Lack of MDM2 amplification in human leukemia. Br J Haemtol 86: 407-409
32. Roessner A, Jürgens H (1993) Round cell tumor of bone. Path Res Pract 189: 1111-1136
33. Saenz-Santamaria MC, McNutt NS, Bogdany JK, Shea CR (1995) p53 expression is rare in cutaneous melanomas. Am J Dermatopathol 17: 344-349
34. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning - a laboratory manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press
35. Sarkar FH, Kupsky WJ, Li YW, Sreepathi P (1994) Analysis of p53 gene mutations in human gliomas by polymerase chain reaction - based on single strand conformation polymorphism and DNA sequencing. Diagn Mol Pathol 3: 2-8
36. Schmidt D, Herrmann C, Jürgens H, Harms D (1991) Malignant peripheral neuroectodermal tumors of childhood and adolescense. Virchows Archiv A 406: 351-364
37. Soussi T (1996) The p53 tumour suppressor gene: a model for molecular epidemiology of human cancer. Mol Med today January 32-37
38. Stahl U, Bohle RM, Pollex U, Sagrudny J, Borkhardt A, Blütters-Sawatzki, Schulz A (1997) Ras Protoonkogen Aktivierung in Tumoren der Ewing-Gruppe. Verh Dtsch Ges Path 81: 571
39. Toguchida J, Yamaguchi T, Ritchie B, Beauchamp RL Dayton SH, Herrera GE, Yamamuro T, Kotoura Y, Sasaki MS, Little JB, Weichselbaum RR, Ishizaki K, Yandell DW (1992) Mutation spectrum of the p53 gene in bone and soft tissue sarcomas. Cancer Res 52: 6194-6199
40. Waber PG, Chen J, Nisen PD (1993) infrequency of MDM2 gene amplification in pediatric solid tumors and lack of association with p53 mutations in adult squamous cell carcinomas. Cancer Res 53: 6028-6030
41. Ha protooncogenes in cancers are frequent and show clinical correlation. Science 231: 261-265